Eli Lilly and Co (LLY)
794.34
-1.33
(-0.17%)
USD |
NYSE |
Dec 26, 16:00
793.78
-0.56
(-0.07%)
After-Hours: 20:00
Eli Lilly Research and Development Expense (Annual): 9.313B for Dec. 31, 2023
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Amgen Inc | 4.784B |
| Biogen Inc | 2.462B |
| Regeneron Pharmaceuticals Inc | 4.439B |
| Viking Therapeutics Inc | 63.81M |
| Moderna Inc | 4.845B |